EVOMMUNE ANNOUNCES LATE-BREAKER PRESENTATION OF PHASE 2A DATA FOR EVO301 IN ATOPIC DERMATITIS AT EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY 2026 CONGRESS

Reuters · 1d ago

Please log in to view news